Aarti Drugs standalone net profit rises 5.03% in the March 2018 quarter

Image
Capital Market
Last Updated : May 16 2018 | 5:04 PM IST

Sales rise 16.83% to Rs 314.99 crore

Net profit of Aarti Drugs rose 5.03% to Rs 22.78 crore in the quarter ended March 2018 as against Rs 21.69 crore during the previous quarter ended March 2017. Sales rose 16.83% to Rs 314.99 crore in the quarter ended March 2018 as against Rs 269.61 crore during the previous quarter ended March 2017.

For the full year,net profit declined 2.74% to Rs 73.41 crore in the year ended March 2018 as against Rs 75.48 crore during the previous year ended March 2017. Sales rose 4.75% to Rs 1140.46 crore in the year ended March 2018 as against Rs 1088.72 crore during the previous year ended March 2017.

ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales314.99269.61 17 1140.461088.72 5 OPM %17.3817.46 -15.9516.11 - PBDT46.2338.99 19 150.01144.47 4 PBT36.5830.29 21 112.21107.78 4 NP22.7821.69 5 73.4175.48 -3

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 16 2018 | 4:47 PM IST

Next Story